Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: A 1H-MRS study

Magnetic Resonance in Medicine

Volumn 60, Issue 4, 2008, Pages 782-789

  Rango, M ^a   Cogiamanian, F ^a   Marceglia, S ^a   Barberis, B ^a   Arighi, A ^a   Biondetti, P ^a   Priori, Alberto ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Inositol phosphates; Long term potentiation (LTP); Magnetic resonance spectroscopy; Myoinositol; Transcranial direct current stimulation

Indexed keywords

BRAIN; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYOLS;

DIRECT CURRENT; INOSITOL PHOSPHATE; LONG-TERM POTENTIATIONS; METABOLITE CONTENT; MYO-INOSITOL; N-ACETYL ASPARTATE; PHOSPHOINOSITIDES; STIMULATING ELECTRODES;

MAGNETIC RESONANCE;

INOSITOL; N ACETYLASPARTIC ACID; PHOSPHATIDYLINOSITIDE;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; ELECTRIC CURRENT; ELECTRODE; FEMALE; FRONTAL LOBE; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR CORTEX; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; VISUAL CORTEX;

EID: 53549093620     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21709     Document Type: Article

References (46)

1. Diehl P, Fluck E, Gunter H, Kosfeld R, Seelig J. NMR basic principles and progress. Berlin: Springer-Verlag; 1992. p 55-72.
2. Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 2002;82:736-754.
3. Irvine RF. 20 years of Ins(1,4,5)P3, and 40 years before. Nat Rev Mol Cell Biol 2003;4:586-590.
4. Kim H, McGrath BM, Silverstone PH. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders - focus on magnetic resonance spectroscopy (MRS) studies. Hum Psychopharmacol 2005;20:309-326.
5. Nikita Gamper, Shapiro MS. Regulation of ion transport proteins by membrane phosphoinositides. Nat Rev Neurosci 2007;8:921-934.
6. Ross BD. Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 1991;4:59-63.
7. Priori A. Brain polarization in humans: a reappraisal of an old tool for prolonged non-invasive modulation of brain excitability. Clin Neurophysiol 2003;114:589-595.
8. Priori A, Berardelli A, Rona S, Accornero N, Manfredi M. Polarization of the human motor cortex through the scalp. Neuroreport 1998;9:2257-2260.
9. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000;527:633-639.
10. Nishiyama M, Hong K, Mikoshiba K, Poo MM, Kato K. Calcium stores regulate the polarity and input specificity of synaptic modification. Nature 2000;408:584-588.
11. Lang N, Siebner HR, Ward NS, Lee L, Nitsche MA, Paulus W, Rothwell JC, Lemon RN, Frackowiak RS. How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain? Eur J Neurosci 2005;22:495-504.
12. Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 2006;8:203-204.
13. Boggio PS, Ferrucci R, Rigonatti SP, Covre P, Nitsche M, Pascual-Leone A, Fregni F. Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease. J Neurol Sci 2006;249:31-38.
14. Webster BR, Celnik PA, Cohen LG. Noninvasive brain stimulation in stroke rehabilitation. NeuroRx 2006;3:474-481.
15. Fregni F, Freedman S, Pascual-Leone A. Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques. Lancet Neurol 2007;6:188-191.
16. Ardolino G, Bossi B, Barbieri S, Priori A. Non-synaptic mechanisms underlie the after-effects of cathodal transcutaneous direct current stimulation of the human brain. J Physiol 2005;568:653-663.
17. Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 2001;57:1899-1901.
18. Siegel G, Agranoff B, Albers R, Molinoff P. Basic neurochemistry. New York: Raven Press; 1994.
19. Challis RA, Mistry R, Gray DW, Nahorski SR. Modulation of muscarinic cholinoceptor-stimulated inositol 1,4,5-trisphosphate accumulation by N-methyl-D-aspartate in neonatal rat cerebral cortex. Neuropharmacology 1994;33:15-25.
20. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F, Paulus W. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 2003;553:293-301.
21. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31.
22. Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn Reson Med 1995;33:595-600.
23. Blamire AM, Cader S, Lee M, Palace J, Matthews PM. Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. Magn Reson Med 2007;58:880-885.
24. Geurts JJ, Reuling IE, Vrenken H, Uitdehaag BM, Polman CH, Castelijns JA, Barkhof F, Pouwels PJ. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006;55:478-483.
25. Rango M, Bonifati C, Bresolin N. Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 2006;26:283-290.
26. Rango M, Canesi M, Ghione I, Farabola M, Righini A, Bresolin N, Antonini A, Pezzoli G. Parkinson's disease, chronic hydrocarbon exposure and striatal neuronal damage: a 1-H MRS study. Neurotoxicology 2006;27:164-168.
27. Tong Z, Yamaki T, Harada K, Houkin K. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004;22:1017-1024.
28. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
29. Nitsche MA, Liebetanz D, Lang N, Antal A, Tergau F, Paulus W. Safety criteria for transcranial direct current stimulation (tDCS) in huilions. Clin Neurophysiol 2003;114:2220-2222; author reply 2222-2223.
30. Cedzich C, Pechstein U, Schramm J, Schafer S. Electrophysiological considerations regarding electrical stimulation of motor cortex and brain stem in humans. Neurosurgery 1998;42:527-532.
31. Tate ME. Separation of myoinositol pentaphosphates by moving paper electrophoresis (MPE). Anal Biochem 1968;23:141-149.
32. Pontzer NJ, Chandler LJ, Stevens BR, Crews FT. Receptors, phosphoinositol hydrolysis and plasticity of nerve cells. Prog Brain Res 1990;86:221-225.
33. Billups D, Billups B, Challiss RA, Nahorski SR. Modulation of Gq-protein-coupled inositol trisphosphate and Ca2+ signaling by the membrane potential. J Neurosci 2006;26:9983-9995.
34. Geurts J, Reuling I, Vrenken H, Uitclehaag B, Polman C, Castelijins J, Barkhof F, Pouwels P. Electroconvulsive shock stimulates polyphosphoinositide degradation and inositol triphosphate accumulation in rat cerebrum: lithium pretreatment does not potentiate these changes. Neurosci Lett 1987;80:75-79.
35. Visioli F, Rodriguez de Turco E, Bazan NG. Daily electroconvulsive shock treatment alters the inositol lipid system response in the rat hippocampus. Neurochem Res 1994;19:705-708.
36. Caspar ML, Aregullin MA, Jesch SA, Henry SA. Inositol induces a profound alteration in the pattern and rate of synthesis and turnover of membrane lipids in Saccharomyces cerevisiae. J Biol Chem 2006;281:22773-2285.
37. Brink CB, Viljoen SL, de Kock SE, Stein DJ, Harvey BH. Effects of myo-inositol versus fluoxetine and imipramine pretreatments on serotonin 5HT2A and muscarinic acetylcholine receptors in human neuroblastoma cells. Metab Brain Disord 2004;19:51-70.
38. Kurozumi K, Murayama T, Nomura Y. Generation of inositol phosphates, cytosolic Ca2+, and secretion of noradrenaline in PC12 cells treated with glutamate. FEBS Lett 1990;270:225-228.
39. Baird JG, Nahorski SR. Stimulatory and inhibitory effects of N-methyl-D-aspartate on 3H-inositol polyphosphate accumulation in rat cortical slices. J Neurochem 1991;57:629-635.
40. Kok RD, Steegers-Theunissen RP, Eskes TK, Heerschap A, van den Berg PP. Decreased relative brain tissue levels of inositol in fetal hydrocephalus. Am J Obstet Gynecol 2003;188:978-980.
41. Banerjee S, Hasan G. The InsP3 receptor: its role in neuronal physiology and neurodegeneration. Bioessays 2005;27:1035-1047.
42. Jones R, Waldman A. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurol Res 2004;26:488-495.
43. Levine J. Controlled trials of inositol in psychiatry. Eur Neuropsychopharmacol 1997;7:147-155.
44. Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417:292-295.
45. Preece N, Gadian D, Houseman J, Williams S. Lithium-induced modulation of cerebral inositol phosphate metabolism in the rat: a multinuclear magnetic resonance study in vivo. Lithium 1992;3:287-297.
46. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD. Neuronal and glial metabolite content of the epileptogenic human hippocampus. Ann Neurol 2002;52:635-642.